« Previous
Next »
Fertility and Sterility
Volume 93, Issue 3
, Pages 1016-1019
, February 2010
Improvement in quality-of-life questionnaire measures in obese adolescent females with polycystic ovary syndrome treated with lifestyle changes and oral contraceptives, with or without metformin
References
- . Diagnosis, phenotype, and prevalence of polycystic ovary syndrome. Fertil Steril. 2006;86:1:S7–8
- . Medical progress: polycystic ovary syndrome. N Engl J Med. 1995;333(13):853–861
- . Diagnosis of polycystic ovary syndrome. Clin Obstet Gynecol. 2007;50:168–177
- . The polycystic ovary syndrome. Clin Endocrinol (Oxf.). 1980;12:177–208
- . Quality of life in adolescent girls with polycystic ovary syndrome. AMA. 2002;156(6):556–560
- . Overweight status of adolescent girls with polycystic ovary syndrome: body mass index as mediator of quality of life. Ambulatory Pediatrics. 2005;5(2):107–111
- . Fertility concerns and sexual behavior in adolescent girls with polycystic ovary syndrome implications for quality of life. J Ped and Adolesc Gyn. 2003;16(1):33–37
- . Determinants of health related quality of life in women with polycystic ovary syndrome. Akusherstvo I Ginkekologiia. 2006;45(7):29–34
- Metformin treatment of polycystic ovary syndrome improves health-related quality of life, emotional distress and sexuality. Hum Reprod. 2006;10:1093
- Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS). J Clin Endo & Met. 1998;83(6):1976–1987
- The polycystic ovary syndrome health related quality of life questionnaire (PCOSQ): a validation. Hum Reprod. 2004;9(2):371–377
- . Obesity and lifestyle management in polycystic ovary syndrome. Clin Obst & Gyn. 2007;50(1):277–294
- Trent ME, Upadhya K. Effects of polycystic ovary syndrome on health-related quality of life 2008; www.cdc.gov/hrqol/index.com Expert Review Pharmacoeconomics Res.
- . Prevalence of overweight and obesity among US children, adolescents, and adults, 1999–2002. JAMA. 2004;291(23):2847–2850
- . mood and sexual function in polycystic ovary syndrome: acne. Semin Reprod Med. 2008;26:45–52
M.H.-G. has nothing to disclose. K.D. has nothing to disclose. L.K. has nothing to disclose. D.G. has nothing to disclose. K.H. has nothing to disclose.
Supported by National Institutes of Health grant K23 HD043881-01A1 (K.M.H.) and grant UL1 RR 024160 from the National Center for Research Resources to the University of Rochester, Rochester, New York.
PII: S0015-0282(09)03458-X
doi: 10.1016/j.fertnstert.2009.08.006
© 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Fertility and Sterility
Volume 93, Issue 3
, Pages 1016-1019
, February 2010

